Guillain-Barré syndrome
- 1 December 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 76 (902) , 774-782
Abstract
Guillain-Barré syndrome is an autoimmune disorder encompassing a heterogeneous group of pathological and clinical entities. Antecedent infections are thought to trigger an immune response, which subsequently cross reacts with nerves leading to demyelination or axonal degeneration. Both intravenous immunoglobulin treatment and plasma exchange have been found to be equally beneficial. Several factors are useful in predicting the outcome of these patients.Keywords
This publication has 109 references indexed in Scilit:
- Campylobacter 0:41 isolation in Guillain-Barre syndromeArchives of Disease in Childhood, 1997
- Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barré syndromeRevista do Instituto de Medicina Tropical de São Paulo, 1996
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- Epidemiology of Guillain-Barré syndrome in children: Relationship of oral polio vaccine administration to occurrenceThe Journal of Pediatrics, 1994
- Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in ChinaAnnals of Neurology, 1993
- Brainstem encephalitis and the Miller Fisher syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- ANTIBODIES TO BORRELIA BURGDORFERI IN GUILLAIN-BARRÉ SYNDROMEThe Lancet, 1989
- Guillain-Barré Syndrome After Vaccination With Purified Tetanus ToxoidSouthern Medical Journal, 1987
- Estimation of plasma and urinary catecholamines in Guillain-Barre syndrome.Japanese Journal of Medicine, 1985
- Guillain-Barré Syndrome and the 1978–1979 Influenza VaccineNew England Journal of Medicine, 1981